Linking Cost Sharing to Value: An Unrivaled Yet Unrealized Public Health Opportunity
- 17 April 2007
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 146 (8) , 602-605
- https://doi.org/10.7326/0003-4819-146-8-200704170-00011
Abstract
As the financial burden of cost sharing continues to rise, patients increasingly avoid necessary care, thereby contributing to the high morbidity and mortality of the U.S. population compared with that of other developed countries. The rationale for cost sharing is often based on the moral hazard argument, which states that individuals may overuse care if they do not share in its costs. We evaluate this argument in detail, using it to distinguish between appropriate and inappropriate settings for cost sharing. Cost sharing may be appropriate when health services are of low value (low ratio of benefits to costs), whereas it is inappropriate when health services are of high value (high ratio of benefits to costs). In practice, cost sharing is rarely linked to value, and therefore much of the cost sharing that currently occurs is inappropriate and harmful. Cost-effectiveness analysis is an objective method to estimate the value of health services and may be a way to systematically evaluate whether cost-sharing policies are appropriate. Systematic efforts to discourage inappropriate cost sharing may improve public health.Keywords
This publication has 13 references indexed in Scilit:
- Drug Prices and Value for MoneyJAMA, 2005
- Medicare and Cost-Effectiveness AnalysisNew England Journal of Medicine, 2005
- Is ‘Moral Hazard’ Inefficient? The Policy Implications Of A New TheoryHealth Affairs, 2004
- The Health Effects of Restricting Prescription Medication Use Because of CostMedical Care, 2004
- Suboptimal statin adherence and discontinuation in primary and secondary prevention populationsJournal of General Internal Medicine, 2004
- Pharmacy Benefits and the Use of Drugs by the Chronically IllJAMA, 2004
- The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and SpendingNew England Journal of Medicine, 2003
- Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly PersonsJAMA, 2001
- The economics of moral hazard revisitedJournal of Health Economics, 1999
- Oregon's Medicaid Ranking and Cost- EffectivenessMedical Decision Making, 1996